Collectively, these results suggest that cP104aa interacts with HNRNPK to upregulate c‐MYC expression by inhibiting WWP2‐mediated c‐MYC ubiquitination, thereby promoting RCC proliferation and metastasis. This evidence concerns the gene WWP2 and renal cell carcinoma.